The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Afatinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Afatinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Afatinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Afatinib in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Afatinib include Boehringer Ingelheim, Hengrui Medicine and Beacon Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Afatinib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Afatinib.
Report Scope
The Afatinib market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Afatinib market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Afatinib companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Hengrui Medicine
Beacon Pharma
Segment by Type
30mg Tables
40mg Tables
50mg Tables
25mg Tables
20mg Tables
Others
Segment by Application
Hospital
Clinic
Drug Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Afatinib companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Afatinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Afatinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Afatinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Afatinib in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Afatinib include Boehringer Ingelheim, Hengrui Medicine and Beacon Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Afatinib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Afatinib.
Report Scope
The Afatinib market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Afatinib market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Afatinib companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Hengrui Medicine
Beacon Pharma
Segment by Type
30mg Tables
40mg Tables
50mg Tables
25mg Tables
20mg Tables
Others
Segment by Application
Hospital
Clinic
Drug Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Afatinib companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Afatinib Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 30mg Tables
1.2.3 40mg Tables
1.2.4 50mg Tables
1.2.5 25mg Tables
1.2.6 20mg Tables
1.2.7 Others
1.3 Market by Application
1.3.1 Global Afatinib Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Center
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Afatinib Market Perspective (2019-2030)
2.2 Afatinib Growth Trends by Region
2.2.1 Global Afatinib Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Afatinib Historic Market Size by Region (2019-2024)
2.2.3 Afatinib Forecasted Market Size by Region (2025-2030)
2.3 Afatinib Market Dynamics
2.3.1 Afatinib Industry Trends
2.3.2 Afatinib Market Drivers
2.3.3 Afatinib Market Challenges
2.3.4 Afatinib Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Afatinib Players by Revenue
3.1.1 Global Top Afatinib Players by Revenue (2019-2024)
3.1.2 Global Afatinib Revenue Market Share by Players (2019-2024)
3.2 Global Afatinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Afatinib Revenue
3.4 Global Afatinib Market Concentration Ratio
3.4.1 Global Afatinib Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Afatinib Revenue in 2023
3.5 Afatinib Key Players Head office and Area Served
3.6 Key Players Afatinib Product Solution and Service
3.7 Date of Enter into Afatinib Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Afatinib Breakdown Data by Type
4.1 Global Afatinib Historic Market Size by Type (2019-2024)
4.2 Global Afatinib Forecasted Market Size by Type (2025-2030)
5 Afatinib Breakdown Data by Application
5.1 Global Afatinib Historic Market Size by Application (2019-2024)
5.2 Global Afatinib Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Afatinib Market Size (2019-2030)
6.2 North America Afatinib Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Afatinib Market Size by Country (2019-2024)
6.4 North America Afatinib Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Afatinib Market Size (2019-2030)
7.2 Europe Afatinib Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Afatinib Market Size by Country (2019-2024)
7.4 Europe Afatinib Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Afatinib Market Size (2019-2030)
8.2 Asia-Pacific Afatinib Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Afatinib Market Size by Region (2019-2024)
8.4 Asia-Pacific Afatinib Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Afatinib Market Size (2019-2030)
9.2 Latin America Afatinib Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Afatinib Market Size by Country (2019-2024)
9.4 Latin America Afatinib Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Afatinib Market Size (2019-2030)
10.2 Middle East & Africa Afatinib Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Afatinib Market Size by Country (2019-2024)
10.4 Middle East & Africa Afatinib Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Detail
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Afatinib Introduction
11.1.4 Boehringer Ingelheim Revenue in Afatinib Business (2019-2024)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Hengrui Medicine
11.2.1 Hengrui Medicine Company Detail
11.2.2 Hengrui Medicine Business Overview
11.2.3 Hengrui Medicine Afatinib Introduction
11.2.4 Hengrui Medicine Revenue in Afatinib Business (2019-2024)
11.2.5 Hengrui Medicine Recent Development
11.3 Beacon Pharma
11.3.1 Beacon Pharma Company Detail
11.3.2 Beacon Pharma Business Overview
11.3.3 Beacon Pharma Afatinib Introduction
11.3.4 Beacon Pharma Revenue in Afatinib Business (2019-2024)
11.3.5 Beacon Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Afatinib Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of 30mg Tables
Table 3. Key Players of 40mg Tables
Table 4. Key Players of 50mg Tables
Table 5. Key Players of 25mg Tables
Table 6. Key Players of 20mg Tables
Table 7. Key Players of Others
Table 8. Global Afatinib Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Afatinib Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Afatinib Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Afatinib Market Share by Region (2019-2024)
Table 12. Global Afatinib Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Afatinib Market Share by Region (2025-2030)
Table 14. Afatinib Market Trends
Table 15. Afatinib Market Drivers
Table 16. Afatinib Market Challenges
Table 17. Afatinib Market Restraints
Table 18. Global Afatinib Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Afatinib Market Share by Players (2019-2024)
Table 20. Global Top Afatinib Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Afatinib as of 2023)
Table 21. Ranking of Global Top Afatinib Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Afatinib Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Afatinib Product Solution and Service
Table 25. Date of Enter into Afatinib Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Afatinib Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Afatinib Revenue Market Share by Type (2019-2024)
Table 29. Global Afatinib Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Afatinib Revenue Market Share by Type (2025-2030)
Table 31. Global Afatinib Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Afatinib Revenue Market Share by Application (2019-2024)
Table 33. Global Afatinib Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Afatinib Revenue Market Share by Application (2025-2030)
Table 35. North America Afatinib Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Afatinib Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Afatinib Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Afatinib Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Afatinib Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Afatinib Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Afatinib Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Afatinib Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Afatinib Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Afatinib Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Afatinib Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Afatinib Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Afatinib Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Afatinib Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Afatinib Market Size by Country (2025-2030) & (US$ Million)
Table 50. Boehringer Ingelheim Company Detail
Table 51. Boehringer Ingelheim Business Overview
Table 52. Boehringer Ingelheim Afatinib Product
Table 53. Boehringer Ingelheim Revenue in Afatinib Business (2019-2024) & (US$ Million)
Table 54. Boehringer Ingelheim Recent Development
Table 55. Hengrui Medicine Company Detail
Table 56. Hengrui Medicine Business Overview
Table 57. Hengrui Medicine Afatinib Product
Table 58. Hengrui Medicine Revenue in Afatinib Business (2019-2024) & (US$ Million)
Table 59. Hengrui Medicine Recent Development
Table 60. Beacon Pharma Company Detail
Table 61. Beacon Pharma Business Overview
Table 62. Beacon Pharma Afatinib Product
Table 63. Beacon Pharma Revenue in Afatinib Business (2019-2024) & (US$ Million)
Table 64. Beacon Pharma Recent Development
Table 65. Research Programs/Design for This Report
Table 66. Key Data Information from Secondary Sources
Table 67. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Afatinib Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Afatinib Market Share by Type: 2023 VS 2030
Figure 3. 30mg Tables Features
Figure 4. 40mg Tables Features
Figure 5. 50mg Tables Features
Figure 6. 25mg Tables Features
Figure 7. 20mg Tables Features
Figure 8. Others Features
Figure 9. Global Afatinib Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Afatinib Market Share by Application: 2023 VS 2030
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Drug Center Case Studies
Figure 14. Others Case Studies
Figure 15. Afatinib Report Years Considered
Figure 16. Global Afatinib Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Afatinib Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Afatinib Market Share by Region: 2023 VS 2030
Figure 19. Global Afatinib Market Share by Players in 2023
Figure 20. Global Top Afatinib Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Afatinib as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Afatinib Revenue in 2023
Figure 22. North America Afatinib Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Afatinib Market Share by Country (2019-2030)
Figure 24. United States Afatinib Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Afatinib Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Afatinib Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Afatinib Market Share by Country (2019-2030)
Figure 28. Germany Afatinib Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Afatinib Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Afatinib Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Afatinib Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Afatinib Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Afatinib Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Afatinib Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Afatinib Market Share by Region (2019-2030)
Figure 36. China Afatinib Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Afatinib Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Afatinib Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Afatinib Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Afatinib Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Afatinib Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Afatinib Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Afatinib Market Share by Country (2019-2030)
Figure 44. Mexico Afatinib Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Afatinib Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Afatinib Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Afatinib Market Share by Country (2019-2030)
Figure 48. Turkey Afatinib Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Afatinib Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Boehringer Ingelheim Revenue Growth Rate in Afatinib Business (2019-2024)
Figure 51. Hengrui Medicine Revenue Growth Rate in Afatinib Business (2019-2024)
Figure 52. Beacon Pharma Revenue Growth Rate in Afatinib Business (2019-2024)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
